Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (SHA:600613)

China flag China · Delayed Price · Currency is CNY
6.43
+0.03 (0.47%)
Mar 10, 2026, 2:55 PM CST
3.71%
Market Cap 3.26B
Revenue (ttm) 1.88B
Net Income (ttm) 62.34M
Shares Out 534.07M
EPS (ttm) 0.11
PE Ratio 57.87
Forward PE n/a
Dividend 0.15 (2.34%)
Ex-Dividend Date Jun 5, 2025
Volume 5,877,240
Average Volume 7,312,159
Open 6.39
Previous Close 6.40
Day's Range 6.38 - 6.46
52-Week Range 5.22 - 7.53
Beta 0.63
RSI 52.29
Earnings Date Apr 30, 2026

About SHA:600613

Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd., together with its subsidiaries, operates as a pharmaceutical manufacturing holding investment company in China. The company engages in the research and development, and production of anti-tumor, cardiovascular, cerebrovascular, rheumatism bone pain, tonic and sedative, cold and cough, anti-fungal, gynecology, and other treatment fields. Its products include prescription drugs and OTC products, including products include sodium cantharidate vitamin B6 injection, sodium cantharidin i... [Read more]

Sector Healthcare
Founded 1990
Employees 1,266
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600613
Full Company Profile

Financial Performance

In 2024, SHA:600613's revenue was 2.05 billion, a decrease of -12.48% compared to the previous year's 2.34 billion. Earnings were 71.39 million, an increase of 25.24%.

Financial Statements

News

There is no news available yet.